Home/ Stocks/ DWTX

Dogwood Therapeutics, Inc. Common Stock

DWTX XNAS

$1.80 -0.02 (-1.14%) ▼ 15-min delayed

Open

$1.76

High

$1.80

Low

$1.76

Volume

6.7K

Market Cap

$58.85M

About Dogwood Therapeutics, Inc. Common Stock

Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 8 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-4,986,614	$-0.15
FY 2025	$0	$-34,257,370	$-7.13
Q3 2025	$0	$-15,744,616	$-8.20
Q1 2025	$0	$-10,924,952	$-8.45

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for DWTX yet. Check out our latest market news or earnings calendar.

Get DWTX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Dogwood Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.